Highmark reboots coverage of digital treatments, raising hope among DTx companies
Sept. 9, 2024
Health Tech Correspondent
Highmark Health, a large regional health insurer that also owns a chain of hospitals, is now covering a handful of digital treatments for chronic pain and other conditions for millions of its patients. The move, which could provide a boost to digital therapeutics makers, may feel like déjà vu for close industry observers.
In 2022, Pittsburgh-based Highmark issued a policy stating that it would cover eight Food and Drug Administration-cleared prescription digital therapeutics for people in its commercial plans. Back then, the decision was heralded as a major turning point for a nascent health tech sector that was struggling to secure coverage from insurers.
advertisement
Still, Highmark leaders cautioned at the time that the policy was a first pass and that more administrative work needed to be done before members would see benefits. And indeed, over the last two years, Highmark paid for only a small number of digital treatments under the policy.
STAT+ Exclusive Story
Already have an account? Log in
This article is exclusive to STAT+ subscribers
Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.
Already have an account? Log in
Monthly
$39
Totals $468 per year
$39/month Get StartedTotals $468 per year
Starter
$20
for 3 months, then $399/year
$20 for 3 months Get StartedThen $399/year
Annual
$399
Save 15%
$399/year Get StartedSave 15%
11+ Users
Custom
Savings start at 25%!
Request A Quote Request A QuoteSavings start at 25%!
2-10 Users
$300
Annually per user
$300/year Get Started$300 Annually per user
View All Plans
To read the rest of this story subscribe to STAT+.
Subscribe Log In health tech, Mental Health, STAT+ Submit a correction requestReprints
Newsletter
Tech is transforming health care and life sciences. Our original reporting is here to keep you ahead of the curve.
